Rhinonorm, 35 mcg/dose 200 doses 20 ml
€1.00
Out of stock
(E-mail when Stock is available)
Pharmacological group: antikongestive – alpha-adrenomimetic.
ATX code: R01AA07
Pharmacological effect:
Xylometazoline is an alpha-adrenomimetic used for topical use in ENT practice.
When used topically, xylometazoline causes narrowing of arterioles resulting in decreased hyperemia and edema of nasopharyngeal mucous membranes and decreased secretion. A clear local effect of the drug is revealed in a few minutes and lasts for several hours (up to 6 – 8 hours), manifested in the restoration of patency of nasal passages, sinus holes and Eustachian tubes. Restoration of nasopharyngeal air patency improves the patients’ well-being and reduces the risk of possible complications caused by mucociliary congestion.
Pharmacokinetics:
When administered topically, xylometazoline is virtually not absorbed, so plasma concentrations are very low (not analytically detectable).
Indications
Active ingredient
Composition
1 dose of the drug contains acting substance: xylometazoline hydrochloride 0.035 mg; excipients: benzalkonium chloride (as a 50% solution) 0.028 mg in terms of benzalkonium chloride 0.014 mg, citric acid monohydrate 0.035 mg, sodium citrate dihydrate 0.182 mg, glycerol 85 % 1.680 mg, purified water to 68.390 mg.
How to take, the dosage
Interaction
Special Instructions
Synopsis
Contraindications
– hypersensitivity to xylometazoline or other components of the drug;
– inflammation of the skin, nasal mucosa and crust formation (dry rhinitis);
– use after pituitaryectomy;
– use in children under 2 years of age;
– closed angle glaucoma;
– taking monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants.
With caution:
Perhaps use with caution in patients with arterial hypertension, severe heart disease, hyperthyroidism, diabetes, and long QT interval syndrome.
Side effects
A sensation of burning and dryness of the nasal mucosa;
in rare cases – irritation of the mucous membranes of the nose, mouth and throat, headache and nausea;
Extremely rare (< 1/10000) – arrhythmia, increased blood pressure, increased excitability, skin reactions.
Overdose
Similarities
Weight | 0.055 kg |
---|---|
Shelf life | 3 years, after opening the bottle – 1 year. |
Conditions of storage | The drug should be kept out of reach of children at a temperature not exceeding 25 ° C. |
Manufacturer | Merkle GmbH, Germany |
Medication form | dosed nasal spray |
Brand | Merkle GmbH |
Related products
Buy Rhinonorm, 35 mcg/dose 200 doses 20 ml with delivery to USA, UK, Europe and over 120 other countries.